Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of GNC Holdings Inc (NYSE: GNC) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of GNC Holdings Inc (NYSE: GNC) concerning whether a series of statements by GNC Holdings Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On October 22, 2015, the Oregon Department of Justice filed a lawsuit against GNC Holdings Inc, stating GNC Holdings Inc (NYSE: GNC) of intentionally selling nutritional and dietary supplements containing the unapproved stimulants Picamilon, a drug used to treat neurological conditions and BMPEA, a drug that was never studied in humans.

Following this news, shares of GNC fell $5.73, or 14.24%, to close at $34.50 on October 22, 2015.

Based in Pittsburgh, Pennsylvania, and founded in 1935 GNC Holdings Inc is a specialty retailer of health and wellness products.

If you purchased shares of GNC Holdings Inc (NYSE: GNC) on or before October 22, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185